← Scroll for more →
Financial Statements — JBIO
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 107.25 | 55.09 | 88.44 | 50.11 | 220.94 | 44.22 | 33.75 | 31.12 | 31.07 | 9.12 | 23.49 | 32.18 | 60.90 | 26.57 | 22.40 | 22.42 | 27.46 | 28.14 | 54.20 | 180.88 |
| Short-term Investments | 353.96 | 256.21 | 247.72 | 148.80 | -- | 31.99 | 44.87 | 57.62 | 73.13 | 90.21 | 98.95 | 103.02 | 89.20 | 92.36 | 106.82 | 120.16 | 124.53 | 132.94 | 113.18 | -- |
| Total Current Assets | 471.25 | 318.52 | 348.82 | 201.36 | 222.98 | 77.37 | 80.12 | 90.61 | 110.76 | 103.24 | 124.23 | 137.60 | 152.47 | 120.57 | 131.50 | 145.16 | 153.45 | 165.89 | 174.33 | 183.10 |
| Property, Plant & Equipment | 0.14 | 0.16 | 0.17 | 0.18 | 0.15 | 0.00 | 0.01 | 0.01 | 0.23 | 0.26 | 0.29 | 0.32 | 0.25 | 0.27 | 0.24 | 0.33 | 0.32 | 0.29 | 0.19 | 0.16 |
| Total Non-current Assets* | 0.86 | 0.92 | 0.97 | 1.09 | 0.98 | 0.16 | 0.22 | 0.35 | 0.93 | 3.58 | 3.19 | 3.27 | 3.29 | 3.82 | 3.81 | 2.50 | 2.24 | 1.11 | 1.03 | 1.02 |
| Total Assets | 472.11 | 319.43 | 349.78 | 202.45 | 223.97 | 77.53 | 80.33 | 90.96 | 111.69 | 106.82 | 127.42 | 140.88 | 155.76 | 124.39 | 135.30 | 147.66 | 155.68 | 167.00 | 175.36 | 184.13 |
| Accounts Payable | 6.58 | 3.98 | 2.15 | 1.35 | 7.59 | 0.07 | 0.22 | 0.91 | 4.18 | 3.31 | 2.40 | 3.50 | 5.53 | 4.73 | 2.58 | 4.54 | 2.07 | 2.86 | 1.21 | 2.56 |
| Total Current Liabilities | 31.57 | 22.29 | 16.54 | 22.36 | 21.62 | 2.42 | 3.83 | 10.32 | 17.02 | 15.52 | 17.64 | 14.73 | 13.28 | 10.64 | 7.78 | 7.71 | 3.76 | 4.70 | 2.55 | 3.83 |
| Total Non-current Liabilities* | 0.63 | 0.68 | 0.72 | 0.75 | 0.79 | 0.07 | 0.07 | 0.15 | 0.28 | 0.40 | 0.33 | 0.43 | 0.55 | 0.66 | 0.78 | 0.81 | 0.88 | 0.35 | 0.40 | 0.45 |
| Total Liabilities | 32.20 | 22.97 | 17.26 | 23.10 | 22.41 | 2.49 | 3.90 | 10.47 | 17.30 | 15.92 | 17.96 | 15.15 | 13.83 | 11.30 | 8.56 | 8.52 | 4.63 | 5.05 | 2.95 | 4.28 |
| Retained Earnings | (270.52) | (214.76) | (174.39) | (142.46) | (117.28) | (235.57) | (233.05) | (227.62) | (211.38) | (186.61) | (163.42) | (143.01) | (123.45) | (104.42) | (87.90) | (72.88) | (59.29) | (47.30) | (36.39) | (28.17) |
| Total Stockholder Equity | 439.92 | 296.46 | 332.52 | 179.35 | 201.56 | 75.05 | 76.43 | 80.49 | 94.40 | 90.90 | 109.46 | 125.72 | 141.93 | 113.10 | 126.74 | 139.14 | 151.05 | 161.95 | 172.42 | 179.85 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | 50.07 | 36.05 | 28.54 | 22.01 | 22.55 | -- | 1.53 | 10.33 | 21.25 | 20.08 | 17.81 | 16.88 | 16.03 | 13.49 | 12.22 | 10.78 | 8.36 | 7.26 | 5.05 | 3.42 |
| Selling, General & Admin | 8.85 | 7.39 | 6.41 | 5.39 | 5.23 | 3.39 | 4.87 | 7.08 | 4.92 | 4.54 | 4.25 | 4.48 | 4.30 | 4.15 | 3.63 | 3.37 | 3.85 | 3.76 | 3.22 | 2.78 |
| Total Operating Expenses | 58.92 | 43.45 | 54.98 | 27.40 | 27.78 | 3.39 | 6.40 | 17.41 | 26.17 | 24.62 | 22.07 | 21.37 | 20.34 | 17.64 | 15.85 | 14.15 | 12.22 | 11.02 | 8.27 | 6.20 |
| Operating Income | (58.92) | (43.44) | (54.98) | (27.40) | (27.78) | (3.39) | (6.40) | (17.41) | (26.16) | (24.62) | (22.07) | (21.37) | (20.34) | (17.64) | (15.85) | (14.15) | (12.21) | (11.02) | (8.27) | (6.20) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.08 |
| Pretax Income | (55.75) | (40.35) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | (10.91) | -- | -- |
| Tax Provision | 0.02 | 0.02 | 0.06 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | (55.76) | (40.37) | (67.58) | (25.17) | (32.13) | (2.52) | (5.43) | (16.24) | (24.77) | (23.19) | (20.41) | (19.56) | (19.02) | (16.52) | (15.02) | (13.59) | (11.99) | (10.91) | (8.22) | (6.18) |
| Basic EPS | (0.76) | (0.57) | (1.76) | (0.48) | (0.86) | (0.09) | (0.19) | (0.56) | (0.86) | (0.83) | (0.73) | (0.71) | (0.76) | (0.67) | (0.60) | (0.56) | (0.49) | (0.45) | -- | -- |
| Diluted EPS | (0.76) | (0.57) | (1.76) | (0.48) | (0.86) | (0.09) | (0.19) | (0.56) | (0.86) | (0.83) | (0.73) | (0.71) | (0.76) | (0.67) | (0.61) | (0.56) | -- | -- | -- | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (43.66) | (24.08) | (33.65) | (22.12) | (36.53) | (2.38) | (11.05) | (16.04) | (20.43) | (23.67) | (14.80) | (15.61) | (14.94) | (11.42) | (14.86) | (9.72) | (8.88) | (5.66) | (13.09) | (6.53) |
| Capital Expenditures | -- | -- | 0.00 | 0.06 | 0.14 | -- | -- | -- | -- | -- | 0.06 | 0.03 | 0.03 | 0.02 | 0.00 | 0.03 | 0.13 | 0.03 | 0.09 | 0.06 |
| Free Cash Flow* | -- | -- | (33.65) | (22.18) | (36.67) | -- | -- | -- | -- | -- | (14.86) | (15.64) | (14.97) | (11.44) | (14.87) | (9.75) | (9.01) | (5.69) | (13.18) | (6.58) |
| Investing Cash Flow | (97.63) | (8.47) | (98.16) | (148.71) | (12.99) | 12.85 | 13.13 | 16.07 | 18.00 | 8.83 | 5.65 | (13.13) | 3.98 | 15.38 | 14.49 | 4.64 | 8.19 | (20.40) | (113.34) | (0.06) |
| Financing Cash Flow | 193.52 | (0.79) | 170.16 | 0.00 | 190.61 | -- | 0.55 | 0.02 | 24.38 | 0.47 | 0.46 | 0.02 | 45.29 | 0.22 | 0.36 | 0.04 | 0.00 | 7.88 | (0.25) | 128.31 |
← Scroll for more columns →
* Derived from reported values